We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > TNX-1800

News List

Tonix reports positive Covid-19 vaccine efficacy results in non-human primates dosed with TNX-1800 pharmaceutical-technology
March 18, 2021
Tonix Pharmaceuticals Holding has reported preliminary positive results after vaccination of non-human primates with TNX-1800, a live modified horsepox virus vaccine for percutaneous administration that is designed to express the Spike protein of ...
Tonix and Southern Research to study immune responses to Covid-19 pharmaceutical-technology
June 19, 2020
Tonix Pharmaceuticals has expanded its ongoing partnership with non-profit Southern Research to study T-cell immune responses to SARS-CoV-2, the novel coronavirus that causes Covid-19.
Tonix and Fujifilm Enter COVID-19 Vax Deal contractpharma
June 09, 2020
Collaboration includes development of manufacturing processes and supply of clinical trial material to support Tonix’s development of TNX-1800.